[EN] HCV HELICASE INHIBITORS AND METHODS OF USE THEREOF<br/>[FR] INHIBITEURS DE L'HÉLICASE DU VHC ET LEURS PROCÉDÉS D'UTILISATION
申请人:UNIV KANSAS
公开号:WO2013036749A1
公开(公告)日:2013-03-14
The present invention discloses thioflavine S and primuline derivatives which inhibit hepatitis C virus helicase and protease activity. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are useful as antiviral agents. The present invention further relates to pharmaceutical compositions containing the aforementioned compounds and methods of treating an HCV infection.
本发明揭示了硫黄素S和原黄素衍生物,可抑制丙型肝炎病毒的解旋酶和蛋白酶活性。因此,本发明的化合物干扰丙型肝炎病毒的生命周期,并可用作抗病毒剂。本发明还涉及含有上述化合物的药物组合物和治疗HCV感染的方法。